Skip to main content

About BXPLANT

BXPLANT is a CDRO (Clinical Development and Research Organization) that bridges R&D and clinical development. As a co-development partner, we design integrated strategies encompassing development planning, regulatory affairs, and clinical operations to deliver optimal pathways for drug development.

R&D
Specialized in Clinical Development
CRO
Contract Research Organization
CDRO
Clinical Development & Operations
Full-Spectrum Development Expertise

Integrated solutions across preclinical strategy, clinical execution, and regulatory affairs—delivering seamless transitions and accelerated timelines from discovery to approval.

Strategic Development Partnership

Beyond conventional CRO services—we integrate development strategy with operational execution, bridging critical gaps from preclinical insight to market realization.

Our Approach

Seamless translation from preclinical to clinical through strategic design and flawless execution. As One Team, we embrace a Sponsor Point of View—delivering adaptive, stage-appropriate solutions with unwavering speed and precision.

Meet Our Leadership: Proven Expertise Driving Your Success

BXPLANT’s leadership team comprises seasoned pharmaceutical and clinical development professionals who have guided countless programs from concept to commercialization. We deliver integrated, sponsor-focused solutions spanning the entire development continuum—identifying promising innovations, architecting strategic development pathways, executing global clinical programs, and facilitating growth capital and partnerships.

Minkeun Jo / Chief Executive Officer

PhD Candidate in Business Administration, Kyung Hee University
Master’s Degree in Pharmacy, Sungkyunkwan University
Master’s Degree in Economics, Korea University
Bachelor’s Program in Law, Chung-Ang University

• Chief Executive Officer, BXPLANT

• Head of Strategic Planning Division, Woojung BIO

• Head of Consumer Healthcare Business Division, Daewoong Pharmaceutical

Heesun Kim PhD, RPh / Chief Executive Officer

PhD in Clinical Research Design, Sungkyunkwan University
Bachelor’s & Master’s Degrees in Pharmacy, Sookmyung Women’s University

• Chief Executive Officer, BXPLANT
Adjunct Professor, Department of Pharmacy, CHA University

• Head of Clinical Development, NextGen Bioscience

• Director of Clinical and Regulatory Affairs, Inventage Lab

• Head of Clinical Development Center, Daewoong Pharmaceutical

Il Hwan Kim DVM, Executive Director

MS & PhD in Veterinary Pathology, Chungnam Nat’l Univ.

  • Chief Executive Officer, V1BIO
  • AI Drug Discovery / Nonclinical, Daewoong Pharmaceutical
  • Pharmacology & Toxicology Team, CJ
  • Toxicologic Pathology Team, KRICT TRC

Sung Il Kim, Managing Director

MS in Life Sciences, GIST

  • Drug Development Division, ImmunoBiome
  • Development Strategy, Y-Biologics
  • Drug Development Division, TSD Life Science
  • Clinical Development Team, LG Life Sciences

Su Young Lee BN, Director

BN, Dongguk Univ. College of Medicine

  • Clinical Development Team, Jeil Pharmaceutical
  • Clinical Development Center, Daewoong Pharmaceutical
  • Clinical Team, Sewon Cellontech

Ji Young You, Director

MBA in Strategy/Management, Yonsei Univ.

MS in Biological Sciences, Seoul Nat’l Univ.

  • Clinical Team, NA Vaccine Inst.
  • Clinical Strategy, CKD
  • Clinical Research Science, HANDOK
  • MW Team, DreamCIS

Jung Hyun Yoo RPh, Executive Director

BSc in Medicinal Chemistry, Sookmyung Women’s Univ.

  • Clinical Team, Daewoong Pharmaceutical
  • Panolos Bioscience
  • BNP Lab

Eun Hye Kim, Director

MS in Statistics, Dongguk Univ.

  • Medical Device Dept., Synex
  • Clinical Statistics Team, Synex
  • DM·STAT, Hanmi Pharmaceutical
  • DM·STAT, CKD

Yu Kyong Kim PhD, Team Lead

PhD in Biomedical Sciences, Seoul Nat’l Univ.

BSc in Biomedical Science, Univ. of Sheffield, UK

  • Clinical / RA·QA Team, Kobiolabs
  • Clinical Strategy Planning, Basgenbio
  • Clinical Team, Daewoong Pharmaceutical
  • Research Prof., Clinical Pharmacology and Therapeutics, CBNUH
  • Main Sub-Investigator, Clinical Pharmacology and Therapeutics, SNUH

Jeong Ah Yoon, Team Lead

MS in Biotechnology, Konkuk Univ.

  • Clinical Development Team, Progen Pharmaceuticals
  • Product Strategy RA, CGBio
  • Global BD, Daewoong Pharmaceutical
  • RA Division, Medi Help Line
  • Licensing & Registration Team, Overseas Certification Management Center

Donghwee Kim, Team Lead

  • Clinical Team, Boryung Pharmaceutical
  • Clinical Team, Medytox

Soo Hee Bae, Team Lead

MS in Medical Statistics, Yonsei Univ.

  • DM·STAT, Medytox
  • DM·STAT, CKD

Seulki Kim, Team Lead

MS in Nursing, Korea Univ.

  • Clinical Strategy Office, Boryung Pharmaceutical
  • Clinical Center, Addpharma
  • Medical Affairs Division, Green Cross

Haesung Jung, Team Lead

BSc in Computer Engineering, HUFS

  • DM Team, MBIO
  • DM Team, PPC Korea
  • DM/STAT Team, BioInfra

Hong Chul Yoon PhD, Advisor / Professor

PhD in Biomedical Science & Medicinal Chemistry, Yonsei Univ.

  • Inst. of Convergence Technology, Yonsei Univ.
  • Advisor, S2C Bio
  • Managing Director, Yunovia
  • Research HQ Managing Director, IL-DONG Pharm.
  • Postdoc, Calibr (CA, USA)

Jung Jin Lee PhD, Advisor

PhD in Microbiology (Immunology), Seoul Nat’l Univ.

  • Chief Executive Officer, CKD Bio
  • R&D Division Director, Binex
  • Bio Research HQ Director, Daewoong Pharm.
  • Head of Vaccine Business Division, LG Life Sciences

Hyun Joo Kim, Advisor

MS in Chemistry, Pusan Nat’l Univ.

  • IP & R&D Planning, AptaBio
  • R&D Planning, Daewoong Pharm.
  • R&D Strategy Team, Daewoong Pharm.
  • Central Research Inst., JW Pharm.

Won No Yoon, Partner / R.Ph.

MS in Pharmaceutical Sciences, Sungkyunkwan Univ.

  • Central Research Inst., Onyu Pharm.
  • New Drug Research Lab., Ahn-Gook Pharm.
  • New Drug Research Lab., SK Chemicals